查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613263

全球DNA修復藥物市場（依藥物類型、劑型、作用機制、應用、通路）：未來預測（2025-2030）

DNA Repair Drugs Market by Drug Type (Alkylating Agents, Poly ADP Ribose Polymerase Inhibitors), Form (Capsules, Injectables, Tablets), Mechanism of Action, Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年DNA修復藥物市值為85.8億美元，預計2024年將達到91.8億美元，複合年成長率為7.20%，到2030年將達到139.7億美元。

DNA修復藥物市場主要涉及旨在修復受損DNA以治療各種遺傳疾病和癌症的治療藥物的開發和商業化。對此類藥物的需求是由環境因素和生活方式改變引起的癌症和基因突變的日益流行所推動的。 DNA修復藥物主要應用於腫瘤學，以恢復正常細胞功能，對於治療乳癌、卵巢和前列腺癌等癌症至關重要。最終用途範圍包括醫院、專科診所和研究機構，重點是推進治療性介入。影響成長的關鍵因素包括製藥公司增加研發投資、對遺傳疾病的更好理解以及實現精準醫療的技術進步。對個人化醫療的日益關注代表著一個重大的商機，因為個人的遺傳訊息可用於提供量身定做的治療並改善患者的治療結果。然而，市場開拓面臨開發成本高、監管核准流程冗長等限制。基因改造也存在潛在副作用和倫理問題等挑戰。

主要市場統計
基準年[2023] 85.8億美元
預測年份 [2024] 91.8億美元
預測年份 [2030] 139.7億美元
複合年成長率（%） 7.20%

也就是說，存在一些潛在的機會。公司可以考慮與生物技術公司合作，結合專業知識並加速創新和產品開發。投資 CRISPR 和人工智慧藥物發現等最尖端科技可以開發更精確的治療方法並提供競爭優勢。將 DNA 修復藥物與免疫療法和標靶治療結合的聯合治療的研究可能會擴大治療的可能性。創新應著重於提高藥物療效，同時最大限度地減少副作用，確保藥物易於取得且具成本效益。市場本質上是在不斷發展的，因此保持敏捷非常重要。企業需要隨時了解最新的監管指南和新興趨勢，以利用市場變化。

市場動態：揭示快速發展的 DNA 修復藥物市場的關鍵市場洞察

DNA 修復藥物市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界上慢性病和遺傳疾病的增加
    • 擴大臨床試驗和研發以促進發展
    • 政府努力促進複雜疾病的治療
  • 市場限制因素
    • DNA修復藥物的配方問題與複雜性
  • 市場機會
    • 持續創新，提高DNA修復藥物的功效與安全性
    • 消費者偏好個人化和精細化策略來管理複雜疾病
  • 市場挑戰
    • 與功效和安全性問題相關的限制

波特五力：駕馭 DNA 修復藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。它為評估公司的競爭力和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解 DNA 修復藥物市場的外部影響

外部宏觀環境因素在塑造 DNA 修復藥物市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解DNA修復藥物市場的競爭格局

DNA 修復藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：DNA 修復藥物市場供應商的績效評估

FPNV定位矩陣是評估DNA修復藥物市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃 DNA 修復藥物市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對 DNA 修復藥物市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估市場範圍和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析最近的產品發布、開拓的地區、關鍵產業進展以及塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1. 目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3. 塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 哪些收益來源和策略機會推動供應商的進入/退出策略？

目錄

第1章簡介

第2章 分析方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性病和遺傳疾病的發生率正在增加
      • 擴大臨床試驗和研究舉措以開發 DNA 修復藥物
      • 政府努力促進複雜疾病的治療
    • 抑制因素
      • DNA修復藥物配方的問題與複雜性
    • 機會
      • 持續創新提高DNA修復藥物的功效與安全性
      • 消費者偏好個人化和精確的策略來管理複雜疾病
    • 任務
      • 與功效和安全性問題相關的限制
  • 市場區隔分析
    • 劑型：顯著引入用於快速給藥的注射劑
    • 應用：擴大DNA修復藥物治療在腫瘤標靶給藥的應用
  • 波特五力分析
  • PESTEL分析
    • 政治因素
    • 經濟因素
    • 社會因素
    • 技術因素
    • 法律因素
    • 環境因素

第6章 DNA 修復藥物市場：依藥物類型

  • 烷化劑
  • 聚 ADP 核糖聚合酵素抑制劑

第7章 DNA修復藥物市場：按形態

  • 膠囊
  • 注射
  • 藥片

第8章 DNA修復藥物市場：按作用機制

  • 鹼基切除修復調節劑
  • 雙鏈修復調節器
  • 失配修復調節器
  • 單鏈修復調節器

第9章 DNA修復藥物市場：依應用分類

  • 神經系統疾病
  • 瘤
    • 乳癌
    • 卵巢癌
    • 攝護腺癌

第10章DNA修復藥物市場：依分銷管道分類

  • 醫院藥房
  • 網路藥房

第11章 北美、南美DNA修復藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章 亞太地區DNA修復藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東、非洲DNA修復藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭情境分析
    • 默克與江蘇恆瑞藥業有限公司合作徹底改變癌症治療
    • F. Hoffmann-La Roche AG 與 KSQ Therapeutics, Inc. 在癌症治療 DNA 修復藥物方面的合作與創新
    • FDA核准新的聯合治療攜帶基因突變的進行性前列腺癌
  • 戰略分析和建議

公司名單

  • Artios Pharma
  • AstraZeneca PLC
  • Aurigene Discovery Technologies
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • CanBas Co., Ltd.
  • Clovis Oncology
  • Corden Pharma International GmbH
  • Eli Lilly and Company
  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Hanson Wade Group
  • Johnson & Johnson Services, Inc.
  • Merck KgaA
  • Novartis AG
  • Pfizer Inc.
  • Valerio Therapeutics
Product Code: MRR-99555D550531

The DNA Repair Drugs Market was valued at USD 8.58 billion in 2023, expected to reach USD 9.18 billion in 2024, and is projected to grow at a CAGR of 7.20%, to USD 13.97 billion by 2030.

The DNA repair drugs market primarily involves the development and commercialization of therapeutics aimed at repairing damaged DNA to treat various genetic disorders and cancers. The necessity for these drugs is driven by the increasing prevalence of cancer and genetic mutations, often stemming from environmental factors and lifestyle changes. DNA repair drugs find application primarily in oncology to restore the normal functioning of cells and are integral in treating cancers such as breast, ovarian, and prostate cancer. The end-use scope encompasses hospitals, specialized clinics, and research institutes that focus on advancing therapeutic interventions. Key influencing growth factors include the rising investments in R&D by pharmaceuticals, an increasing understanding of genetic disorders, and advancements in technology enabling precision medicine. The burgeoning focus on personalized medicine presents a significant opportunity, as leveraging individual genetic information can lead to customized therapies, improving patient outcomes. However, the market faces limitations such as high development costs and lengthy regulatory approval processes. Challenges also include potential side effects and ethical concerns regarding genetic modifications.

KEY MARKET STATISTICS
Base Year [2023] USD 8.58 billion
Estimated Year [2024] USD 9.18 billion
Forecast Year [2030] USD 13.97 billion
CAGR (%) 7.20%

Nevertheless, there are several potential opportunities. Companies should consider partnerships with biotech firms to combine expertise, which could fast-track innovation and product development. Investment in cutting-edge technologies like CRISPR and AI-driven drug discovery could lead to more precise treatment modalities and provide a competitive edge. Research into combination therapies that incorporate DNA repair drugs with immunotherapies or targeted therapies may expand therapeutic potential. Innovation should focus on increasing drug efficacy while minimizing adverse effects, ensuring drugs are accessible and cost-effective. The market is inherently fast-evolving, so maintaining agility is key; firms should stay updated on regulatory guidelines and emerging trends to capitalize on market shifts.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA Repair Drugs Market

The DNA Repair Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of chronic and genetic diseases across the world
    • Expanding clinical trials and research initiatives to develop DNA repair drugs
    • Government initiatives to promote access to treatments for complex diseases
  • Market Restraints
    • Formulation issues and complexities of DNA repair drugs
  • Market Opportunities
    • Ongoing innovations to improve the efficacy and safety of DNA repair drugs
    • Consumer preference for personalized and precision strategies to manage complex diseases
  • Market Challenges
    • Limitations associated with efficacy and safety concerns

Porter's Five Forces: A Strategic Tool for Navigating the DNA Repair Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA Repair Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the DNA Repair Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA Repair Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the DNA Repair Drugs Market

A detailed market share analysis in the DNA Repair Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA Repair Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA Repair Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the DNA Repair Drugs Market

A strategic analysis of the DNA Repair Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA Repair Drugs Market, highlighting leading vendors and their innovative profiles. These include Artios Pharma, AstraZeneca PLC, Aurigene Discovery Technologies, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, CanBas Co., Ltd., Clovis Oncology, Corden Pharma International GmbH, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline PLC, Hanson Wade Group, Johnson & Johnson Services, Inc., Merck KgaA, Novartis AG, Pfizer Inc., and Valerio Therapeutics.

Market Segmentation & Coverage

This research report categorizes the DNA Repair Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Alkylating Agents and Poly ADP Ribose Polymerase Inhibitors.
  • Based on Form, market is studied across Capsules, Injectables, and Tablets.
  • Based on Mechanism of Action, market is studied across Base Excision Repair Modulators, Double-strand Break Repair Modulators, Mismatch Repair Modulators, and Single-strand Break Repair Modulators.
  • Based on Application, market is studied across Neurological Diseases and Oncology. The Oncology is further studied across Breast Cancer, Ovarian Cancer, and Prostate Cancer.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies and Online Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of chronic and genetic diseases across the world
      • 5.1.1.2. Expanding clinical trials and research initiatives to develop DNA repair drugs
      • 5.1.1.3. Government initiatives to promote access to treatments for complex diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Formulation issues and complexities of DNA repair drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations to improve the efficacy and safety of DNA repair drugs
      • 5.1.3.2. Consumer preference for personalized and precision strategies to manage complex diseases
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with efficacy and safety concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Form: Significant adoption of injectables for quick delivery of medication
    • 5.2.2. Application: Growing application of DNA repair drug therapy in targeted drug delivery in oncology
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. DNA Repair Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Alkylating Agents
  • 6.3. Poly ADP Ribose Polymerase Inhibitors

7. DNA Repair Drugs Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Injectables
  • 7.4. Tablets

8. DNA Repair Drugs Market, by Mechanism of Action

  • 8.1. Introduction
  • 8.2. Base Excision Repair Modulators
  • 8.3. Double-strand Break Repair Modulators
  • 8.4. Mismatch Repair Modulators
  • 8.5. Single-strand Break Repair Modulators

9. DNA Repair Drugs Market, by Application

  • 9.1. Introduction
  • 9.2. Neurological Diseases
  • 9.3. Oncology
    • 9.3.1. Breast Cancer
    • 9.3.2. Ovarian Cancer
    • 9.3.3. Prostate Cancer

10. DNA Repair Drugs Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies

11. Americas DNA Repair Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific DNA Repair Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa DNA Repair Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Merck KGaA and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Forge Alliance to Advance Cancer Treatment Innovations
    • 14.3.2. Collaboration and Innovations in Cancer Treatment by F. Hoffmann-La Roche AG and KSQ Therapeutics, Inc. in DNA Repair Drugs
    • 14.3.3. FDA Approves New Combination Therapy for Advanced Prostate Cancer Featuring Genetic Mutations
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Artios Pharma
  • 2. AstraZeneca PLC
  • 3. Aurigene Discovery Technologies
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bristol-Myers Squibb Company
  • 6. CanBas Co., Ltd.
  • 7. Clovis Oncology
  • 8. Corden Pharma International GmbH
  • 9. Eli Lilly and Company
  • 10. Genentech, Inc.
  • 11. GlaxoSmithKline PLC
  • 12. Hanson Wade Group
  • 13. Johnson & Johnson Services, Inc.
  • 14. Merck KgaA
  • 15. Novartis AG
  • 16. Pfizer Inc.
  • 17. Valerio Therapeutics

LIST OF FIGURES

  • FIGURE 1. DNA REPAIR DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. DNA REPAIR DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. DNA REPAIR DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. DNA REPAIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DNA REPAIR DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DNA REPAIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DNA REPAIR DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY POLY ADP RIBOSE POLYMERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BASE EXCISION REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DOUBLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY MISMATCH REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY SINGLE-STRAND BREAK REPAIR MODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DNA REPAIR DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES DNA REPAIR DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DNA REPAIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM DNA REPAIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 279. DNA REPAIR DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. DNA REPAIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2023